Effects of Sodium Bicarbonate Supplementation on Intermittent and Intense Task

Sponsor
University of Nove de Julho (Other)
Overall Status
Unknown status
CT.gov ID
NCT03837886
Collaborator
Marcelo Martins Kalytczak (Other)
12
1
2
1.3
8.9

Study Details

Study Description

Brief Summary

The aim of this study was to verify if sodium bicarbonate (NaHCO3) suplementation promotes changes in the performance, muscular activity and strength of individuals trained during the intermittent and intense task . Twelve trained adult men will participate in this randomized, double-blind, crossover clinical trial. Each participant should receive two types of intervention with a 14-day interval between conditions: alkalosis (ALK) in which gelatinous capsules containing 0.3 g.kg -1 of NaHCO 3 and placebo (PLA) are administered, in which 0.3 g.kg-1 of Calcium Carbonate (CaCO3). The following results will be considered: electromyographic activity (EMG) of the quadriceps muscle, peak torque, pH, lactate, and perception of effort, recovery and pain questionnaires, which will be collected during intermittent and high intensity DI protocol. ANOVA of repeated measures will be used to verify possible differences between groups.

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: Sodium bicarbonate
  • Dietary Supplement: Calcium carbonate
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
12 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose:
Other
Official Title:
Sodium Bicarbonate Supplementation Promotes Changes in Performance, Muscle Activity and Strength of Individuals Trained During the Performance of Intermittent and Intense Task? Randomized, Double-blind, Crossover Trial
Anticipated Study Start Date :
Oct 20, 2019
Anticipated Primary Completion Date :
Oct 30, 2019
Anticipated Study Completion Date :
Nov 30, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: Alkalosis group

The subjects should receive gelatinous capsules containing 0.3 g.kg -1 of sodium bicarbonate

Dietary Supplement: Sodium bicarbonate
The subjects should ingest 0.3g.kg of sodium bicarbonate 90 minutes before the beginning of the protocol task.

Placebo Comparator: Placebo group

The subjects should receive gelatinous capsules containing 0.3 g.kg -1 of Calcium Carbonate

Dietary Supplement: Calcium carbonate
The subjects should receive gelatinous capsules containing 0.3 g.kg -1 of Calcium Carbonate

Outcome Measures

Primary Outcome Measures

  1. Electromyographic activity of the femoral quadriceps evaluated with electromyography equipment [60 minutes]

    The electromyographic activity will be obtained during the execution of 10 series composed of ten repetitions of extension (concentric phase) and flexion (eccentric phase) of the knee joint, at an angular velocity of 120os-1 (radians per second), with interval of 1 minute interval between sets in an isokinetic dynamometer.

  2. Peak torque assessed with isokinetic dynamometer equipment [60 minutes]

    The peak torque will be obtained during the execution of 10 series composed of ten repetitions of extension (concentric phase) and flexion (eccentric phase) of the knee joint, at an angular velocity of 120os-1 (radians per second), with interval of 1 minute interval between sets.

Secondary Outcome Measures

  1. Lactate assessed with portable lactometer [15 seconds]

    The lactate quantification will be performed before and after the test session characterized by the execution of 10 series composed of ten repetitions of extension (concentric phase) and flexion (eccentric phase) of the knee joint, at an angular velocity of 120os-1 (radians per second), with an interval of 1 minute between sets in an isokinetic dynamometer.

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years to 42 Years
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • resistance trained men (minimum 12 moths resistance training experience)
Exclusion Criteria:
  • diabetes mellitus;

  • respiratory (asthma, COPD), renal, metabolic, rheumatic and cardiovascular disorders;

  • acid-base balance disorder;

  • continuous use of some type of medication;

  • use of high-protein supplementation and creatine supplementation;

  • users of anabolic steroids.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Nove de Julho University São Paulo Brazil 06454050

Sponsors and Collaborators

  • University of Nove de Julho
  • Marcelo Martins Kalytczak

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Fabiano Politti, Principal Investigator, University of Nove de Julho
ClinicalTrials.gov Identifier:
NCT03837886
Other Study ID Numbers:
  • FP001
First Posted:
Feb 12, 2019
Last Update Posted:
Oct 17, 2019
Last Verified:
Oct 1, 2019
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 17, 2019